That myth has finally been debunked through countless studies over several years while more recent data now indicate that low serum testosterone levels are a potential predictor of high-risk prostate cancer. Because of this potential risk, practitioners are often reluctant to administer testosterone in patients they believe may be at high risk for prostate cancer or whom they suspect may have the low-grade disease. Many longitudinal studies investigating the relationship of endogenous testosterone levels and subsequent risk of prostate cancer failed to find any association. The current consensus among medical experts is that TRT, or testosterone replacement therapy, does not directly cause prostate cancer. For men who clearly have testosterone deficiency, there is no apparent increased risk of heart attack or stroke or greater chance of developing a new prostate cancer from testosterone replacement therapy.
Testosterone Replacement Therapy (TRT) is specifically designed for men experiencing clinically significant low levels of testosterone, a condition known as hypogonadism. Deciding to undergo TRT is a significant step and should be made in consultation with a healthcare provider. Once administered, it works to offset the decline in natural testosterone production, thereby helping to maintain normal bodily functions that rely on this crucial hormone.
More research is needed to fully understand the long-term effects. BPH is the enlargement of the prostate gland, which can cause urinary problems. However, significantly elevated PSA levels or rapidly rising PSA levels would warrant further investigation and may preclude TRT until the underlying cause is determined. PSA stands for Prostate-Specific Antigen, a protein produced by the prostate gland. This typically includes a PSA blood test and a digital rectal exam (DRE). The benefits of TRT are often substantial for men with clinically diagnosed hypogonadism.
TRT is a specialized treatment aimed at men with clinically diagnosed hypogonadism who exhibit symptoms that significantly impact their quality of life. Deciding to embark on TRT involves a collaborative process between the patient and healthcare provider. While older men are more likely to experience low testosterone, age alone isn’t a determinant for therapy. Before initiating TRT, it’s crucial to evaluate the individual’s overall health. However, the decision to start TRT isn’t solely based on these numbers; it also considers the severity of symptoms and overall health. Diagnosing low testosterone requires more than just identifying symptoms. This section focuses on identifying the candidates for TRT, understanding the symptoms, and the process of diagnosing low testosterone.
The hypothalamus doesn’t really concern itself with whether the testosterone in your system came from a TRT injection or was produced naturally. FSH is responsible for initiating spermatization (the production of sperm), and LH plays a key role in testosterone production. Your hypothalamus produces gonadotropin-releasing hormone (GnRH) that signals the pituitary gland to generate two key fertility hormones, which are known as luteinizing hormone (LH) and follicular stimulating hormone (FSH).
Patients are sometimes concerned the potential correlation between TRT and gynecomastia. There aren’t a lot of guarantees, but reasonable measures can be taken to lessen the negative impact that exogenous testosterone and TRT has on fertility. If having a family in the traditional manner is still a goal for you, holding off on treatment for a period of time is one option. However, for men who do not want to risk not being able to father a child, banking sperm before starting TRT makes sense. HCG and other medications such as clomiphene can potentially be beneficial in this scenario as they do not result in lower sperm counts.
Your clinician will order the appropriate blood tests and review results with you to determine eligibility. However, you’re welcome to share your Gameday results with your primary care provider if you choose. Gameday provides targeted diagnostics, same-day results, and treatment options dedicated to men’s vitality. Testosterone pellets offer a slow-release solution for consistent hormone balance over months at a time. It’s a safe, non-invasive treatment that improves erectile function, sensation, and long-term performance without medication. This option is ideal for men seeking a guided, medically supervised approach to sustainable weight-management results. Beneficial for men with confirmed hormone deficiency and performance-focused goals.

Gender: Female

Social links